title: Genomic copy number alterations in clear cell renal carcinoma: associations with case characteristics and mechanisms of VHL gene inactivation.
abstract: Array comparative genomic hybridization was used to identify copy number alterations in clear cell renal cell carcinoma (ccRCC) patient tumors to identify associations with patient/clinical characteristics. Of 763 ccRCC patients, 412 (54%) provided frozen biopsies. Clones were analyzed for significant copy number differences, adjusting for multiple comparisons and covariates in multivariate analyses. Frequent alterations included losses on: 3p (92.2%), 14q (46.8%), 8p (38.1%), 4q (35.4%), 9p (32.3%), 9q (31.8%), 6q (30.8%), 3q (29.4%), 10q (25.7%), 13q (24.5%), 1p (23.5%) and gains on 5q (60.2%), 7q (39.6%), 7p (30.6%), 5p (26.5%), 20q (25.5%), 12q (24.8%), 12p (22.8%). Stage and grade were associated with 1p, 9p, 9q, 13q and 14q loss and 12q gain. Males had more alterations compared with females, independent of stage and grade. Significant differences in the number/types of alterations were observed by family cancer history, age at diagnosis and smoking status. Von Hippel-Lindau (VHL) gene inactivation was associated with 3p loss (P<E-05), and these cases had fewer alterations than wild-type cases. The fragile site flanking the FHIT locus (3p14.2) represented a unique breakpoint among VHL hypermethylated cases, compared with wild-type cases and those with sequence changes. This is the first study of its size to investigate copy number alterations among cases with extensive patient, clinical/risk factor information. Patients characterized by VHL wild-type gene status (vs sequence alterations) and male (vs female) cases had more copy number alterations regardless of diagnostic stage and grade, which could relate to poor prognosis.
authors.affiliation: Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), Bethesda, MD, USA.
authors.forename: L E
authors.initials: LE
authors.lastname: Moore
authors.forename: E
authors.initials: E
authors.lastname: Jaeger
authors.forename: M L
authors.initials: ML
authors.lastname: Nickerson
authors.forename: P
authors.initials: P
authors.lastname: Brennan
authors.forename: S
authors.initials: S
authors.lastname: De Vries
authors.forename: R
authors.initials: R
authors.lastname: Roy
authors.forename: J
authors.initials: J
authors.lastname: Toro
authors.forename: H
authors.initials: H
authors.lastname: Li
authors.forename: S
authors.initials: S
authors.lastname: Karami
authors.forename: P
authors.initials: P
authors.lastname: Lenz
authors.forename: D
authors.initials: D
authors.lastname: Zaridze
authors.forename: V
authors.initials: V
authors.lastname: Janout
authors.forename: V
authors.initials: V
authors.lastname: Bencko
authors.forename: M
authors.initials: M
authors.lastname: Navratilova
authors.forename: N
authors.initials: N
authors.lastname: Szeszenia-Dabrowska
authors.forename: D
authors.initials: D
authors.lastname: Mates
authors.forename: W M
authors.initials: WM
authors.lastname: Linehan
authors.forename: M
authors.initials: M
authors.lastname: Merino
authors.forename: J
authors.initials: J
authors.lastname: Simko
authors.forename: R
authors.initials: R
authors.lastname: Pfeiffer
authors.forename: P
authors.initials: P
authors.lastname: Boffetta
authors.forename: S
authors.initials: S
authors.lastname: Hewitt
authors.forename: N
authors.initials: N
authors.lastname: Rothman
authors.forename: W-H
authors.initials: WH
authors.lastname: Chow
authors.forename: F M
authors.initials: FM
authors.lastname: Waldman
references.citation: Am J Epidemiol. 2007 Jul 1;166(1):62-70
references.pmid: 17456477
references.citation: Cancer J. 2008 Sep-Oct;14(5):288-301
references.pmid: 18836333
references.citation: Science. 1993 May 28;260(5112):1317-20
references.pmid: 8493574
references.citation: Future Oncol. 2008 Feb;4(1):85-92
references.pmid: 18241003
references.citation: Clin Cancer Res. 2009 Dec 15;15(24):7582-7592
references.pmid: 19996202
references.citation: Neoplasia. 2008 Jul;10(7):634-42
references.pmid: 18592004
references.citation: Br J Cancer. 2009 Oct 20;101(8):1417-24
references.pmid: 19755989
references.citation: BJU Int. 2006 Oct;98(4):756-62
references.pmid: 16827904
references.citation: J Urol. 2003 Dec;170(6 Pt 1):2163-72
references.pmid: 14634372
references.citation: Genome Biol. 2004;5(10):R80
references.pmid: 15461798
references.citation: Cancer Res. 2010 Aug 15;70(16):6527-36
references.pmid: 20663906
references.citation: Nat Rev Cancer. 2002 Sep;2(9):673-82
references.pmid: 12209156
references.citation: Int J Cancer. 2009 Nov 15;125(10):2342-8
references.pmid: 19521957
references.citation: Oncol Rep. 2005 May;13(5):859-64
references.pmid: 15809750
references.citation: Nature. 1999 May 20;399(6733):271-5
references.pmid: 10353251
references.citation: Genes Chromosomes Cancer. 2011 Jul;50(7):479-88
references.pmid: 21456047
references.citation: Br J Cancer. 2008 Dec 2;99(11):1912-5
references.pmid: 19034282
references.citation: Nat Genet. 2001 Dec;29(4):459-64
references.pmid: 11694878
references.citation: Cancer Res. 2002 Feb 15;62(4):957-60
references.pmid: 11861363
references.citation: Biostatistics. 2004 Oct;5(4):557-72
references.pmid: 15475419
references.citation: PLoS Genet. 2011 Oct;7(10):e1002312
references.pmid: 22022277
references.citation: Nat Genet. 1998 Oct;20(2):207-11
references.pmid: 9771718
references.citation: Am J Pathol. 1997 Dec;151(6):1541-7
references.pmid: 9403704
references.citation: Bioinformatics. 2005 Nov 15;21(22):4084-91
references.pmid: 16159913
references.citation: Lancet Oncol. 2002 Dec;3(12):748-54
references.pmid: 12473516
references.citation: J Natl Cancer Inst. 2002 Oct 16;94(20):1569-75
references.pmid: 12381710
references.citation: Cancer Cell. 2006 Dec;10(6):529-41
references.pmid: 17157792
references.citation: Clin Cancer Res. 2008 Sep 1;14(17):5531-9
references.pmid: 18765545
references.citation: Stat Appl Genet Mol Biol. 2004;3:Article3
references.pmid: 16646809
references.citation: Cancer Res. 2009 Jun 1;69(11):4674-81
references.pmid: 19470766
references.citation: ScientificWorldJournal. 2010 Jun 16;10:1142-51
references.pmid: 20563537